NITRIC OXIDE AND TUMOR PROMOTION

一氧化氮与肿瘤促进

基本信息

  • 批准号:
    6124460
  • 负责人:
  • 金额:
    $ 27.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-12-24 至 2001-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: This is a proposal to investigate the role of reactive nitrogen species in skin tumor promotion in mice. Considerable recent evidence indicates that both reactive nitrogen and oxygen species are formed in skin treated with tumor promoter tetradecanoylphorbol acetate (TPA) in a multistage carcinogenesis (DMBA/TPA) model and in skin treated chronically with the complete carcinogen DMBA. The hypothesis to be investigated in this project is that reactive nitrogen intermediates produced by inflammatory leukocytes present in the dermis and the dermal/epidermal junction cause oxidative DNA damage that leads to mutations and affects clonal expansion of initiated cell populations through the selective induction of apoptosis. This hypothesis will be addressed through three specific aims. Studies in aim 1 will characterize changes in the expression of genes for inducible nitric oxide synthase (iNOS) and endothelial NOS (eNOS) as well as the induction of apoptosis in epidermis of mice subjected to a DMBA/TPA protocol or multiple treatments with DMBA alone. Studies in Aim 2 will investigate the effects of modulation of NO production with the NOS inhibitor monomethyl-L-arginine monoacetate (L-NMMA) or the NO-releasing compound DETA/NO in the DMBA/TPA or DMBA-only protocols. Parameters to be investigated include NOS gene expression, vascular permeability, skin thickness, vascular endothelial growth factor and vascular permeability factor induction, NO and peroxynitrite production, leukocyte infiltration, apoptosis, and oxidative DNA damage. Studies in aim 3 will attempt to determine the nature of the reactive nitrogen species involved in mutagenesis and the mutations they produce in an in vitro co-culture system employing AS52 cells exposed to oxidants or incubated in co-culture with peripheral leukocytes isolated from DMBA/TPA or DMBA treated mice. Mutations in the gpt gene of the AS52 cells will be characterized.
描述:这是一项研究活性物作用的提案

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
v-Ha-ras Tg.AC 转基因小鼠和 FVB/N 小鼠的皮肤、乳头状瘤和癌中新型血管内皮生长因子/血管通透性因子转录物的比较表达。
  • DOI:
    10.1006/bbrc.1998.8787
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tober,KL;Cannon,RE;Spalding,JW;Oberyszyn,TM;Parrett,ML;Rackoff,AI;Oberyszyn,AS;Tennant,RW;Robertson,FM
  • 通讯作者:
    Robertson,FM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FREDIKA A ROBERTSON其他文献

FREDIKA A ROBERTSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FREDIKA A ROBERTSON', 18)}}的其他基金

NITRIC OXIDE AND TUMOR PROMOTION
一氧化氮与肿瘤促进
  • 批准号:
    2462954
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    6172945
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    6376215
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
INFLAMMATION AND MULTISTAGE CARCINOGENESIS
炎症和多期致癌
  • 批准号:
    2733319
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
NITRIC OXIDE AND TUMOR PROMOTION
一氧化氮与肿瘤促进
  • 批准号:
    2837792
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    2683636
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
INFLAMMATION AND MULTISTAGE CARCINOGENESIS
炎症和多期致癌
  • 批准号:
    6172864
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
INFLAMMATION AND MULTISTAGE CARCINOGENESIS
炎症和多期致癌
  • 批准号:
    2405128
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
INFLAMMATION AND MULTISTAGE CARCINOGENESIS
炎症和多期致癌
  • 批准号:
    2895808
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:
GENE SPECIFIC MUTATIONS IN SKIN INDUCED BY PEROXYNITRITE
过氧亚硝酸盐引起的皮肤基因特异性突变
  • 批准号:
    2895481
  • 财政年份:
    1997
  • 资助金额:
    $ 27.41万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 27.41万
  • 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 27.41万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 27.41万
  • 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 27.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 27.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 27.41万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 27.41万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 27.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 27.41万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 27.41万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了